-
1
-
-
0034177707
-
Adherence to triple therapy and viral load response
-
Low-Beer S, Yip B, O'Shaughnessy MV, Hogg RS, Montaner JS. Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr. 2000;23:360-361.
-
(2000)
J Acquir Immune Defic Syndr
, vol.23
, pp. 360-361
-
-
Low-Beer, S.1
Yip, B.2
O'Shaughnessy, M.V.3
Hogg, R.S.4
Montaner, J.S.5
-
2
-
-
0034604276
-
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
-
Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intem Med. 2000;133:21-30.
-
(2000)
Ann Intem Med
, vol.133
, pp. 21-30
-
-
Paterson, D.L.1
Swindells, S.2
Mohr, J.3
-
3
-
-
0034457843
-
Factors affecting adherence to antiretroviral therapy
-
Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(suppl 2):S171-176.
-
(2000)
Clin Infect Dis
, vol.30
, Issue.SUPPL. 2
-
-
Chesney, M.A.1
-
4
-
-
0035477744
-
Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the her study
-
Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001;28:124-131.
-
(2001)
J Acquir Immune Defic Syndr
, vol.28
, pp. 124-131
-
-
Stone, V.E.1
Hogan, J.W.2
Schuman, P.3
-
5
-
-
0033370077
-
Didanosine: An updated review of its use in HIV infection
-
Perry CM, Noble S. Didanosine: an updated review of its use in HIV infection. Drugs. 1999;58:1099-1135.
-
(1999)
Drugs
, vol.58
, pp. 1099-1135
-
-
Perry, C.M.1
Noble, S.2
-
6
-
-
0035998756
-
Bioequivalence of two formulations of didanosine, encapsulated enteric-coated beads and buffered tablet, in healthy volunteers and HIV-infected subjects
-
Damle BD, Kaul S, Behr D, Knupp C. Bioequivalence of two formulations of didanosine, encapsulated enteric-coated beads and buffered tablet, in healthy volunteers and HIV-infected subjects. J Clin Pharmacol. 2002;42:791-797.
-
(2002)
J Clin Pharmacol
, vol.42
, pp. 791-797
-
-
Damle, B.D.1
Kaul, S.2
Behr, D.3
Knupp, C.4
-
7
-
-
85047697366
-
Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads
-
Damle BD, Yan JH, Behr D, et al. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads. J Clin Pharmacol. 2002;42:419-427.
-
(2002)
J Clin Pharmacol
, vol.42
, pp. 419-427
-
-
Damle, B.D.1
Yan, J.H.2
Behr, D.3
-
8
-
-
19944428772
-
Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)
-
Iribarren JA, Labarga P, Rubio R, et al. [Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)]. Enferm Infecc Microbiol Clin. 2004;22:564-642.
-
(2004)
Enferm Infecc Microbiol Clin
, vol.22
, pp. 564-642
-
-
Iribarren, J.A.1
Labarga, P.2
Rubio, R.3
-
9
-
-
0036097706
-
Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazole
-
Damle B, Hess H, Kaul S, Knupp C. Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazole. Biopharm Drug Dispos. 2002;23:59-66.
-
(2002)
Biopharm Drug Dispos
, vol.23
, pp. 59-66
-
-
Damle, B.1
Hess, H.2
Kaul, S.3
Knupp, C.4
-
10
-
-
0036148655
-
Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin
-
Damle BD, Mummaneni V, Kaul S, Knupp C. Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin. Antimicrob Agents Chemother. 2002;46:385-391.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 385-391
-
-
Damle, B.D.1
Mummaneni, V.2
Kaul, S.3
Knupp, C.4
-
11
-
-
0942290559
-
Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1
-
Parkin NT, Hellmann NS, Whitcomb JM, Kiss L, Chappey C, Petropoulos CJ. Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2004;48:437-443.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 437-443
-
-
Parkin, N.T.1
Hellmann, N.S.2
Whitcomb, J.M.3
Kiss, L.4
Chappey, C.5
Petropoulos, C.J.6
-
12
-
-
0027453574
-
Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS
-
Ruhnke M, Bauer FE, Seifert M, Trautmann M, Hille H, Koeppe P. Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS. Antimicrob Agents Chemother. 1993;37:2153-2158.
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 2153-2158
-
-
Ruhnke, M.1
Bauer, F.E.2
Seifert, M.3
Trautmann, M.4
Hille, H.5
Koeppe, P.6
-
13
-
-
0026080378
-
Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal
-
Lotterer E, Ruhnke M, Trautmann M, Beyer R, Bauer FE. Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal. Eur J Clin Pharmacol. 1991;40:305-308.
-
(1991)
Eur J Clin Pharmacol
, vol.40
, pp. 305-308
-
-
Lotterer, E.1
Ruhnke, M.2
Trautmann, M.3
Beyer, R.4
Bauer, F.E.5
-
14
-
-
0028848484
-
The effect of food on pharmacokinetics of zalcitabine in HIV-positive patients
-
Nazareno LA, Holazo AA, Limjuco R, et al. The effect of food on pharmacokinetics of zalcitabine in HIV-positive patients. Pharm Res. 1995;12:1462-1465.
-
(1995)
Pharm Res
, vol.12
, pp. 1462-1465
-
-
Nazareno, L.A.1
Holazo, A.A.2
Limjuco, R.3
-
15
-
-
0027471409
-
Anomalous accumulation and decay of 2′,3′-dideoxyadenosine-5′-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2′,3′-dideoxyinosine
-
Ahluwalia G, Cooney DA, Hartman NR, et al. Anomalous accumulation and decay of 2′,3′-dideoxyadenosine-5′-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2′,3′-dideoxyinosine. Drug Metab Dispos. 1993;21:369-376.
-
(1993)
Drug Metab Dispos
, vol.21
, pp. 369-376
-
-
Ahluwalia, G.1
Cooney, D.A.2
Hartman, N.R.3
-
16
-
-
0034689292
-
Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children
-
Pediatric AIDS Clinical Trials Group Protocol 144 Study Team
-
Stevens RC, Rodman JH, Yong FH, Carey V, Knupp CA, Frenkel LM. Effect of food and pharmacokinetic variability on didanosine systemic exposure in HIV-infected children. Pediatric AIDS Clinical Trials Group Protocol 144 Study Team. AIDS Res Hum Retroviruses. 2000;16:415-421.
-
(2000)
AIDS Res Hum Retroviruses
, vol.16
, pp. 415-421
-
-
Stevens, R.C.1
Rodman, J.H.2
Yong, F.H.3
Carey, V.4
Knupp, C.A.5
Frenkel, L.M.6
-
17
-
-
16844379887
-
Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunters
-
la Porte C, Verweij-van Wisen C, van Ewijk N, et al. Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunters. J Clin Pharmacol. 2005;45:211-218.
-
(2005)
J Clin Pharmacol
, vol.45
, pp. 211-218
-
-
la Porte, C.1
Verweij-van Wisen, C.2
van Ewijk, N.3
-
18
-
-
0033215016
-
Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients
-
The STADI Group
-
Reynes J, Denisi R, Massip P, Izopet J, Pellegrin I, Segondy M. Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients. The STADI Group. J Acquir Immune Defic Syndr. 1999;22:103-105.
-
(1999)
J Acquir Immune Defic Syndr
, vol.22
, pp. 103-105
-
-
Reynes, J.1
Denisi, R.2
Massip, P.3
Izopet, J.4
Pellegrin, I.5
Segondy, M.6
-
19
-
-
0035715574
-
Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz
-
Maggiolo F, Migilorino M, Maserati R, et al. Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz. Antivir Ther. 2001;6:249-253.
-
(2001)
Antivir Ther
, vol.6
, pp. 249-253
-
-
Maggiolo, F.1
Migilorino, M.2
Maserati, R.3
|